Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
255.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.394%)
Market Cap: £340.51m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Financing Arrangements

29 Jul 2009 17:21

RNS Number : 5234W
Mavinwood PLC
29 July 2009
Β 

ο»Ώ

Mavinwood plc

Financing ArrangementsΒ and Board Resignations

Mavinwood plc announces that further to its trading update on 19 June it has reached agreement to refinance its existing debtΒ and has today entered into a facility agreement with LloydsΒ TSBΒ BankΒ plc ("Lloyds").Β 

The new facilityΒ agreementΒ providesΒ three year amortising facilities of up to Β£19.5m andΒ will provide the Company with term, revolving and overdraft facilities part of which will be used to refinanceΒ the Company'sΒ existing borrowings.Β 

The facility documents contain covenants, representations and warranties and events of default which are standard for these types of facilities.Β Β There is an additional requirement that the Geraldton Underwriting CommitmentΒ (as referred toΒ below)Β be complied with andΒ that the CompanyΒ raisesΒ a minimum of Β£6mΒ in cashΒ by 30 September 2009. There are also a number of financial covenants the Company is required to comply withΒ on an ongoing basis.

Β 

In connection with the new banking arrangements,Β GeraldtonΒ Services, Inc. ("Geraldton"), the Company's principal shareholder, has agreed to extend its commitment to provide additional equity to the Company and to vary the terms of its underwriting commitment given to the Company in February 2009Β (as previously extended and varied in June 2009)Β (the "Geraldton Underwriting Commitment").

Geraldton remains committed to increase its investment in the Company by up to Β£10m (less any amounts raised by the Company pursuant to the issue of ordinary shares to persons other than Geraldton)Β by subscribing for new shares in the Company. Geraldton has agreed to vary the Geraldton Underwriting Commitment so as toΒ invest Β£6m (less any amounts raised by the issue of shares to other persons) on or before 30 September 2009.Β Β Geraldton has agreed to invest a further sum of up to Β£4m on or before 31 January 2010 if the ratio of net debt to EBITDA on 31 December 2009 as tested under theΒ Company'sΒ new facility agreement with Lloyds exceeds an agreed level. If the ratio does exceed the agreed level, Geraldton will invest such further amount (less any amounts raised by the issue of shares to other persons) as would ensure thatΒ the ratio would not have exceeded the agreed levelΒ if such amounts had been held by the Company on 31 December 2009Β and would not be exceeded as retested as at 31 January 2010. If and to the extent Geraldton cannot increase its investment as described above by way of subscriptions for shares, Geraldton has agreed to provide such sums by way of loan.

TheΒ previously announcedΒ fee of Β£900,000 payable by the Company to Geraldton in connection withΒ theΒ GeraldtonΒ Underwriting Commitment and the short term facility of Β£2.5m made available to the Company by GeraldtonΒ remains payable whether or not they are called upon by the Company.Β The Company has drawn down approximately Β£2 million in relation to the short term facility to date.

Geraldton is a related party (as defined in the AIM Rules) and theΒ variation of theΒ Geraldton Underwriting Commitment constitutes a related party transaction under the AIM Rules. TheΒ Board considers, having consulted with its nominated adviser,Β Collins Stewart,Β the terms of theΒ variation to theΒ Geraldton Underwriting Commitment to be fair and reasonable in so far as the Company's shareholders are concerned.Β For the purpose of the variation to the Geraldton Underwriting Commitment, Mr Wilson is not regarded as an "independent" director because of his informal links to Lord Ashcroft KCMG, who controls Geraldton. It was therefore agreed that Mr Wilson would not vote, and did not vote, at the Board meeting when the above relatedΒ party transaction was voted on.

Resignation of Directors

Mavinwood has also announced that Kevin Mahoney, Executive Director, and Mike Vincent, Finance Director, have resigned from the Board with effect from 31 July 2009 to pursue other business interests.

Enquiries to

Mavinwood plc

Charles Skinner 07966 234 075

Threadneedle Communications

John Coles 020 7653 9848

Collins Stewart Europe Limited

Adrian Hadden/Jon Drage 020 7523 8350

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCQKLFLKDBFBBK
Date   Source Headline
23rd Jul 20187:00 amRNSHalf Year Trading Update
20th Jul 201812:33 pmRNSHolding(s) in Company
9th Jul 201812:35 pmRNSHolding(s) in Company
5th Jul 20184:11 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSHolding(s) in Company
3rd Jul 20189:56 amRNSHolding(s) in Company
25th Jun 20183:43 pmRNSDirector/PDMR Shareholding
29th May 201812:23 pmRNSDirector/PDMR Shareholding
21st May 20183:19 pmRNSResult of AGM
21st May 20187:00 amRNSAGM Statement
1st May 20188:15 amRNSCompletion of Acquisition
26th Apr 20183:41 pmRNSExercise of Options
20th Apr 201812:02 pmRNSHolding(s) in Company
10th Apr 20184:43 pmRNSNotice of GM
10th Apr 201810:23 amRNSHolding(s) in Company
6th Apr 201811:50 amRNSDirector/PDMR Shareholding
5th Apr 201812:30 pmRNSDirector/PDMR Shareholding
29th Mar 201810:18 amRNSHolding(s) in Company
28th Mar 20181:24 pmRNSDirector/PDMR Shareholding
26th Mar 201811:55 amRNSDirector/PDMR Shareholding
26th Mar 20187:00 amRNSAcquisition
21st Mar 20185:05 pmRNSAnnual Report and Notice of AGM
13th Mar 20187:00 amRNSFinal Results
30th Jan 20187:00 amRNSYear End Trading Update
12th Jan 20181:09 pmRNSExercise of Options
11th Dec 20173:01 pmRNSExercise of Options
28th Nov 20177:00 amRNSAppointment of Chairman Designate
7th Nov 20173:55 pmRNSIssue of Equity - Replacement
7th Nov 201712:48 pmRNSIssue of Equity
5th Oct 20175:04 pmRNSHolding(s) in Company
3rd Oct 201710:12 amRNSDirector/PDMR Shareholding
25th Sep 20171:19 pmRNSDirector/PDMR Shareholding
20th Sep 201712:19 pmRNSHolding(s) in Company
19th Sep 201712:18 pmRNSExercise of Options
18th Sep 20179:54 amRNSHolding(s) in Company
13th Sep 20174:58 pmRNSHolding(s) in Company
12th Sep 201711:23 amRNSExercise of Options
11th Sep 20177:00 amRNSAcquisition
11th Sep 20177:00 amRNSHalf-year Report
15th Aug 20177:00 amRNSDirectorate Change
15th Aug 20177:00 amRNSAcquisition of Baxter Confidential Limited
25th Jul 20177:00 amRNSHalf Year Trading Update
15th Jun 20177:00 amRNSSite Visit
12th Jun 20175:19 pmRNSHolding(s) in Company
5th Jun 20172:52 pmRNSIssue of Equity
5th Jun 20171:29 pmRNSPDMR Shareholding
22nd May 20173:10 pmRNSResult of AGM
22nd May 20177:00 amRNSAGM Statement
18th May 20173:46 pmRNSHolding(s) in Company
5th May 20173:36 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.